Literature DB >> 31254710

Surgical Outcomes and Their Correlation with Increasing Surgical Experience in a Series of 250 Ruptured or Unruptured Aneurysms Undergoing Microsurgical Clipping.

Alberto Tomatis1, Gianluca Trevisi2, Beatrice Boido3, Rosa Perez3, Carlo Alberto Benech3.   

Abstract

BACKGROUND: The development of endovascular techniques has offered extraordinary therapeutic opportunities to treat intracranial aneurysms. However, mainly for anterior circulation aneurysms, no clear superiority of these techniques compared with microsurgical clipping has been shown in terms of morbidity, mortality, aneurysm occlusion rate, and long-term protection from recanalization and rebleeding. We reviewed the data from a retrospective case series to determine the clinical and radiological outcomes of clipped ruptured and unruptured aneurysm to analyze the relationship between increasing surgical experience and operative time, recovery time, and clinical outcomes.
METHODS: A total of 250 consecutive aneurysms in 221 patients had been treated from June 2009 to June 2015. The postoperative complications, recovery time (only for the unruptured group), operative time, clinical outcomes, and aneurysm occlusion rate at 3 months were analyzed for both ruptured and unruptured aneurysms. Linear regression was used to analyze the relationship between surgical experience and the operative time, recovery time, and clinical outcomes.
RESULTS: The complication rate was very low in the unruptured cases (117 patients), with 100% of patients in good clinical status at 3 months. In the ruptured cases (104 patients), the presenting neurological status significantly influenced the postoperative outcomes. Complete obliteration found on the 3-month digital subtraction angiogram was obtained for 96.6% of the treated aneurysms in both groups. A significant correlation was found between surgical experience and both the operative time and recovery time.
CONCLUSIONS: In a subset of patients (aneurysm located in the anterior circulation and <12 mm), microsurgical clipping appeared to be as safe as endovascular treatment and can obtain a very high complete occlusion rate. Increasing surgical experience improved the operative time and recovery time, with a trend toward improvement of the clinical outcomes.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endovascular treatment; Intracranial aneurysm; Learning curve; Subarachnoid hemorrhage; Surgical clipping; Surgical experience; Unruptured aneurysm

Year:  2019        PMID: 31254710     DOI: 10.1016/j.wneu.2019.06.150

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  3 in total

1.  Initial experience in the microsurgical treatment of ruptured brain aneurysms in the endovascular era: characteristics and safety of the learning curve in the first 300 consecutively treated patients.

Authors:  Eduardo Vieira; Thiago C Guimarães; Erton C A Pontes; Ana C V Silva; Marcelle C Carneiro; Arlindo U Netto; Lívio Pereira; Auricélio B Cezar; Igor Faquini; Nivaldo S Almeida; Maria F L Griz; Hildo R C Azevedo-Filho
Journal:  Acta Neurochir (Wien)       Date:  2022-03-03       Impact factor: 2.216

2.  Microsurgical and endovascular treatment of un-ruptured cerebral aneurysms by European hybrid neurosurgeons to balance surgical skills and medical staff management.

Authors:  Abdul Rahman Al-Schameri; Som Thakur; Michael Kral; Christoph Schwartz; Slaven Pikija; Camillo Sherif; Friedrich Weymayr; Bernd Richling
Journal:  Acta Neurochir (Wien)       Date:  2021-02-10       Impact factor: 2.216

3.  Clipping versus coiling for treatment of middle cerebral artery aneurysms: a retrospective Italian multicenter experience.

Authors:  Carmelo Lucio Sturiale; Alba Scerrati; Luca Ricciardi; Oriela Rustemi; Anna Maria Auricchio; Nicolò Norri; Amedeo Piazza; Fabio Ranieri; Alberto Tomatis; Alessio Albanese; Vincenzo Di Egidio; Marco Farneti; Annunziato Mangiola; Enrico Marchese; Antonino Raco; Lorenzo Volpin; Gianluca Trevisi
Journal:  Neurosurg Rev       Date:  2022-06-04       Impact factor: 2.800

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.